Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
Trial record 1 of 10 for:    ALKS 3831
Previous Study | Return to List | Next Study

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02873208
Recruitment Status : Completed
First Posted : August 19, 2016
Last Update Posted : October 30, 2019
Sponsor:
Information provided by (Responsible Party):
Alkermes, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 17, 2019
Actual Study Completion Date : October 17, 2019